Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
23 Both peptides are approved for human use in Russia
Quick Navigation Report Overview Key Takeaways Product Type Analysis Route of Administration Analysis Application Analysis Distribution Channel Analysis Key Market Segments Drivers Restraints Opportunities Impact of Macroeconomic / Geopolitical Factors Latest Trends Regional Analysis Key Players Analysis Recent Developments Report Scope Report Overview Global GLP-1 Receptor Agonist Market size is expected to be worth around US$ 268.4 billion by 2034 from US$ 53.5 billion in 2024, growing at a CAGR of 17.5% during the forecast period 2025 to 2034
Zepbound has a GLP-1 receptor agonist and a GIP stimulant
It works by controlling blood sugar levels and reducing hunger, leading to weight loss
US$ 29.44
US$ 25.22
US$ 23.37
US$ 23.04
US$ 24.79
US$ 22.74
US$ 21.88
US$ 20.64
US$ 24.70
US$ 25.73
